期刊
NEUROTOXICITY RESEARCH
卷 40, 期 6, 页码 1673-1689出版社
SPRINGER
DOI: 10.1007/s12640-022-00582-8
关键词
Paclitaxel; Chemotherapy; Neuropathic Pain; Neurotoxicity
资金
- Consejo Nacional de Ciencia y Tecnologia (CONACyT) [CVU 854822, 778710]
Chemotherapy is widely used for cancer treatment, but it can lead to chemotherapy-induced peripheral neuropathy (CIPN) with unclear mechanisms.
Chemotherapy is widely used as a primary treatment or adjuvant therapy for cancer. Anti-microtubule agents (such as paclitaxel and docetaxel) are used for treating many types of cancer, either alone or in combination. However, their use has negative consequences that restrict the treatment's ability to continue. The principal negative effect is the so-called chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a complex ailment that depends on diversity in the mechanisms of action of the different chemotherapy drugs, which are not fully understood. In this paper, we review several neurophysiological and pathological characteristics, such as morphological changes, changes in ion channels, mitochondria and oxidative stress, cell death, changes in the immune response, and synaptic control, as well as the characteristics of neuropathic pain produced by paclitaxel.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据